Current status of surgical XXXX .

@entity1 @entity1087 @entity189 @entity260 @entity2737 @entity615 @entity1084 @entity356 @entity420 @entity255
In recent years, the use of nonoperative palliation for unresectable @entity189 has increased markedly, in part, because of the high morbidity and mortality rates after surgical palliation. The current analysis was undertaken to determine whether or not decreases in morbidity and mortality rates, recently observed after resection of @entity189 , are now being seen in the surgical palliation of unresectable @entity189 . During a 54 month period, 118 consecutive @entity1 underwent surgical exploration with the finding of unresectable @entity420 . @entity1087 was the most common complaint at admission, being present in 73 percent of the @entity1 . @entity615 , or both, was present in 71 percent of the @entity1 and weight loss was observed in 61 percent of the @entity1 . The most commonly performed procedure was combined biliary bypass and gastrojejunostomy, being performed upon 75 percent of the @entity1 . A gastrojejunostomy was performed upon 107 of 118 @entity1 (91 percent). The hospital mortality rate was 2.5 percent. @entity260 occurred in 37 percent of the @entity1 but were seldom life-threatening. @entity2737 was the most frequent @entity260 (10 percent), followed by @entity255 (8 percent) and delayed @entity356 (8 percent). During the late follow-up period, only 4 percent of the @entity1 had @entity1084 , and only 2 percent had recurrent @entity1087 . The mean survival time postoperatively was 7.7 months. These results demonstrate that @entity1 with unresectable @entity189 can undergo surgical palliation with minimal perioperative mortality, acceptable morbidity and good long term palliation. We conclude that surgical palliation is the treatment of choice for carefully selected @entity1 with unresectable @entity189 .
